Amphista Therapeutics Achieves Breakthrough in Cancer Target Degradation Amphista Therapeutics, a leader in next-generation targeted protein degradation (TPD), has published a study in Nat…
Evaxion Appoints New CEO Evaxion A/S (NASDAQ: EVAX), a clinical-stage TechBio company, has appointed Dr. Helen Tayton-Martin as its new Ch…
FTSE Mixed as UK Lags Global Rally London stocks opened mixed on Monday, with the FTSE 100 edging up 0.1% to 9,651.66 as the UK market lag…
Bulls Shake Off Illness to Claim ALM Win Over Reds Macarthur FC have defeated Adelaide for their first victory of the A-League Men season,…
Trump's Tariffs: Any Road to Relief? Donald Trump has a longstanding fixation with tariffs, once calling them the "greatest thing ever". T…
From Pills to People: The Rise of Social Prescribing Karen Mak brings you a bumper edition blog on social prescribing, finding that rates …
Meralco's 9-Month Profit Increases by 14% Manila Electric Company (Meralco) reported a 14% increase in consolidated core net income, reach…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…
Compulsory Voting: A Remedy or Ruse for Democracy? The debate over compulsory voting revolves around a trade-off between participation and…
London Gateway Tech to Reduce Truck Waiting Times A new automated stacking system at London Gateway is set to improve truck turnaround tim…
AGRITECHNICA: Fraunhofer Presents Innovations for the Agriculture of Tomorrow Climate change, resource scarcity, and growing sustainabilit…